VOYA Investment Management’s PDS Biotechnology PDSB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-12,037
Closed -$59.8K 2856
2023
Q4
$59.8K Buy
12,037
+799
+7% +$3.97K ﹤0.01% 2831
2023
Q3
$56.8K Hold
11,238
﹤0.01% 2838
2023
Q2
$56.5K Buy
+11,238
New +$73.6K ﹤0.01% 2890
2018
Q2
Sell
-514
Closed -$12K 2637
2018
Q1
$12K Hold
514
﹤0.01% 2577
2017
Q4
$96K Hold
514
﹤0.01% 2507
2017
Q3
$110K Hold
514
﹤0.01% 2525
2017
Q2
$106K Buy
+514
New +$101K ﹤0.01% 2555

Other funds holding PDSB

VOYA Investment Management's PDSB Position: Q1 2024 in Review

VOYA Investment Management sold out of PDS Biotechnology (PDSB) in Q1 2024, closing a stake of 12,037 shares — an estimated $59.8K sold.

VOYA Investment Management first reported a position in PDSB in Q2 2017 and held it in 7 quarters. The position peaked at $110K in Q3 2017. 72 funds tracked by Wall St. Rank hold PDSB as of Q1 2024.

  • VOYA Investment Management reported no remaining PDS Biotechnology position as of Q1 2024 after selling out during the quarter.
  • VOYA Investment Management sold 12,037 PDS Biotechnology shares in Q1 2024, an estimated $59.8K.
  • VOYA Investment Management first reported a position in PDS Biotechnology in Q2 2017 and held it in 7 quarters.
  • VOYA Investment Management's PDS Biotechnology position peaked at $110K in Q3 2017.
  • 72 funds tracked by Wall St. Rank held PDS Biotechnology as of Q1 2024.

Based on VOYA Investment Management's 13F filing for Q1 2024, filed 15 May 2024.